Lingyan Su

Title: Innovations of Lingyan Su in Neurodegenerative Disease Treatment

Introduction

Lingyan Su is a notable inventor based in Kunming, China. She has made significant contributions to the field of medicine, particularly in the treatment and prevention of neurodegenerative diseases. Her innovative work has led to the development of a unique pharmaceutical composition aimed at addressing critical health challenges.

Latest Patents

Lingyan Su holds a patent for the "Use of Gemfibrozil and derivative thereof for treatment and/or prevention of neurodegenerative disease." This patent outlines the application of Gemfibrozil, along with its pharmaceutically acceptable salts, esters, or stereoisomers, in creating a medicament for treating or preventing neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and amyotrophic lateral sclerosis. The patent emphasizes the formulation of a pharmaceutical composition that includes Gemfibrozil and potentially one or more pharmaceutically acceptable carriers.

Career Highlights

Lingyan Su is affiliated with the Chinese Academy of Sciences, where she conducts her research and development work. Her dedication to advancing medical science is evident through her innovative patent and ongoing research efforts.

Collaborations

Lingyan Su collaborates with esteemed colleagues, including Yonggang Yao and Rongcan Luo. Their combined expertise contributes to the advancement of research in neurodegenerative diseases.

Conclusion

Lingyan Su's innovative work in the field of neurodegenerative disease treatment showcases her commitment to improving healthcare outcomes. Her patent on Gemfibrozil represents a significant step forward in addressing these challenging conditions.